Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

Research output: Contribution to journalReview article

1 Citation (Scopus)


Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.

Original languageEnglish
JournalInternational Journal of Clinical Oncology
Publication statusPublished - Jan 1 2019



  • Cytotoxic drug
  • Immune checkpoint inhibitor
  • Squamous cell carcinoma of the lung

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Cite this